• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Credit Suisse Lux Biotechnology Equity Fund

+ Add to Watchlist

CLTLU:LX

403.4300 USD 5.6700 1.39%

As of 07:54:00 ET on 12/17/2014.

Snapshot for Credit Suisse Lux Biotechnology Equity Fund (CLTLU)

Open: 403.4300 High - Low: 403.4300 - 403.4300 Primary Exchange: Luxembourg
Volume: 0 52-Week Range: 292.4200 - 432.4800 Beta vs NBI: 0.9266

ETF Chart for CLTLU

No chart data available.
  • CLTLU:LX 403.4300
  • 1D
  • 1M
  • 1Y
409.1000
Interactive CLTLU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CLTLU

Credit Suisse Lux Biotechnology Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.

Inception Date: Telephone: -
Managers: IRENE BEATRICE PUETTNER
Web Site: www.credit-suisse.com

Fundamentals for CLTLU

NAV -
Assets (M) (on 2014-12-16) 219.1939
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for CLTLU

No dividends reported

Performance for CLTLU

1-Month +2.29% 1-Year +33.42%
3-Month +9.12% 3-Year +43.30%
Year To Date +27.70% 5-Year +26.67%
Expense Ratio -

Top Fund Holdings for CLTLU

Filing Date: 09/30/2014
Name Position Value % of Total
Gilead Sciences Inc 185,484 19,744,772 9.635%
Celgene Corp 175,276 16,612,659 8.107%
Amgen Inc 108,973 15,306,348 7.469%
Biogen Idec Inc 42,745 14,140,473 6.900%
Vertex Pharmaceuticals Inc 94,000 10,557,140 5.152%
Regeneron Pharmaceuticals Inc 27,000 9,734,040 4.750%
Alexion Pharmaceuticals Inc 57,752 9,576,437 4.673%
BioMarin Pharmaceutical Inc 120,444 8,691,239 4.241%
Medivation Inc 80,000 7,909,600 3.860%
Incyte Corp 145,000 7,112,250 3.471%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil